Global Biochip Markets: Microarrays and Lab-on-a-Chip

Global Biochip Markets: Microarrays and Lab-on-a-Chip

Report Code: BIO049E

Publish Date: Oct 2013

Publisher: BCC Publishing

Category: Cell Biology

Customize This Report

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global biochip products market reached $3.3 billion in 2012. This market is expected to grow to nearly $3.9 billion in 2013 and $14.4 billion in 2018 at a compound annual growth rate (CAGR) of 30% for the five-year period 2013 to 2018.

Report Includes

  • An overview of the global market for current and emerging biochip technologies and products
  • Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018
  • Characterizations of biochip markets by type (DNA microarray, protein microarray, emerging microarray, and lab-on-a-chip); by function (gene expression, genotyping, micro-RNA, epigenetic, sequence capture); and by end-user (research-and-development tools, drug discovery and development, diagnostics, sequencing, and applied)
  • A focused study on the market for biochip-based diagnostics products, a major future segment for biochips
  • Discussion of the main commercial biochip technologies and the commercial potential of the key market segments
  • Examination of the factors that influence the market, including growth-driving forces, industry alliances and acquisitions, applications in diagnostics and drug discovery, and customer needs
  • Patent analysis
  • Comprehensive company profiles of major players.

INTRODUCTION

STUDY GOALS AND OBJECTIVES

BCC Research’s goal for this study was to determine the status of current and emerging biochip technologies and products and assess their worldwide growth potential over a five-year period from 2013 to 2018.  We were particularly interested in characterizing the biochip markets by type (DNA microarray, protein microarray, emerging microarray, lab-on-a-chip); by function (gene expression, genotyping, micro-RNA, epigenetic, sequence capture); and by end user (R&D tools, drug discovery, and development, diagnostics, sequencing, applied).

A particular focus of this study is the market for biochip-based diagnostics products, which highlights a major future market segment for biochips.

Our key objective was to present a comprehensive discussion of the main commercial biochip technologies and the current and future commercial potential for each of the key market segments.

REASONS FOR DOING THE STUDY

BCC Research previously examined the biochips industry in 2011.  Since 2011, numerous industry alliances and acquisitions have occurred, which changes the competitive dynamics.  In addition, emerging markets for biochips in diagnostics are beginning to gain traction.  These changing industry and market dynamics necessitate a re-examination of the total industry.

The main biochips platforms are also undergoing a transition.  DNA microarrays are being influenced by next-generation sequencing applications, as well as exciting new applications in rapid DNA analysis and diagnostics.  Protein microarrays continue to make progress in the market, as well as emerging microarray classes (tissue/cell and glycomics).

Lab-on-a-chip (LOAC) applications are becoming more important in point of care diagnostics applications, as well as in drug discovery and development.

Next-generation sequencing (NGS) applications continue to increase as a result of lowered costs and better informatics support.

It is important to keep up with these trends and their influence on the biochips market.  This report is intended to guide companies in these industries about the important trends in biochips as well as provide detailed information about the individual market segments and industry dynamics.

CONTRIBUTION OF THE STUDY AND FOR WHOM

BCC Research has compiled a study of the main biochip products that are used in the five end-user segments: research tools, drug discovery and development, diagnostics, sequencing and applied markets.  The report discusses the biochip platforms, market growth driving forces, product types, key market applications, companies and alliances, industry dynamics, patents, future market potential and product sales forecasts for 2013 through 2018.

This study will be of particular interest to the companies in the following industries:  diagnostics, pharmaceuticals, biotechnology, nanotechnology, life-sciences tools, biodefense, medical devices, polymers, glass, materials, bioinformatics, and genetic services.  It will also be of interest to companies involved in drug and/or biomarker discovery programs; manufacturers of microarrays and lab-on-a-chip devices, sequencing instruments; antibodies, restriction enzymes or primers; bioinformatics developers; and cancer researchers and clinicians.

SCOPE AND FORMAT

The study scope includes the major biochip platforms, including DNA and protein microarrays, tissue/cell and glycomics microarrays, LOAC products and next-generation sequencing.  Each platform is analyzed to determine its market status, impact on future market segments, and forecasted growth from 2013 through 2018.  Technology status and market driving forces are discussed.  Factors that influence the market are discussed, including growth driving forces, industry alliances and acquisitions, applications in diagnostics and drug discovery, customer needs and competitive trends.

In addition to the main LOAC, microarray and sequencing industries, BCC Research profiles several specialized biochip industry segments including the following:  DNA analyzers, ion channel screening, digital PCR, label-free detection, nanoarray, peptide microarray, antibody microarray, antibody reagents, multiplex protein diagnostics, circulating tumor cell, prenatal screening, point of care CD4 counting and China’s biochips industries.

Applications for biochips-based diagnostics are highlighted in this report, particularly cancer diagnostics.

New data about biochip substrate types is presented in the report.

BCC Research analyzes patent data for each biochip type.

The industry has grown significantly since the last report, and nearly 300 companies are profiled in this report.

METHODOLOGY

Both primary and secondary research methodologies were used in preparing this study.  BCC Research examines each of the key end-user market segments that will be commercially important during the next five years:  research tools, drug discovery and development, diagnostics, next-generation DNA sequencing and applied markets (biodefense, food safety, ag-bio).

Based on this analysis, we evaluate the potential applications of biochips in each of the major market segments, and forecast sales revenues for 2013 through 2018.

Based on research, detailed market size information is provided for 2012, 2013 and 2018. For DNA microarrays, the market is given by end-use industry, substrate material and analysis type.  For protein and emerging microarrays, the market is given by end-use industry, substrate type and array type.  For LOAC, the market is given by end-use industry and substrate type, as well as by genomic and proteomic use.  For next-generation sequencing, the market is given by end-use industry, substrate material and analysis complexity.

The diagnostics market is given by biochip type and by indication.  The cancer diagnostics market is given by biochip type and cancer indication.

The geographical market sizes for total biochips, LOAC, microarrays and next-generation sequencing are given for North America, Europe, China, Japan and the rest of the world.

INFORMATION SOURCES

BCC Research used primary sources in industry, government and academia, as well as secondary sources for this study.

BCC RESEARCH WEBSITE

BCC Research offers an online information retrieval service. BCC Research’s home page, located at www.bccresearch.com, enables readers to:

  • Examine the complete BCC Research catalog of market research reports and place direct orders.
  • Read announcements of recently published reports.
  • Register for its well-known conferences.
  • Request additional information on any BCC research product.
  • Take advantage of special offers.

DISCLAIMER

The information developed in this report, is intended to be as reliable as possible at the time of publication and of a professional nature. This information does not constitute managerial, legal, or accounting advice; nor should it serve as a corporate policy guide, laboratory manual, or an endorsement of any product, as much of the information is of a speculative in nature. BCC Research and the author assume no responsibility for any loss or damage that might result from reliance on the report information or from its use.

Need pricing for multiple titles, a complete report bundle, or something specially curated to fit your budget? Explore Offers

Analyst Credentials

John Bergin has produced successful and highly regarded market research reports in the life science industry for BCC research for more than 10 years. Mr. Bergin has held business development and international sales and marketing positions with Corning Inc., an advanced materials company. He has also held executive management positions with IBC Advanced Technologies, a molecular recognition company specializing in separations. Mr. Bergin's extensive expertise in commercializing new technologies is reflected in his market research reports.

Mr. Bergin received a BS degree in Chemistry and Masters of Business Administration (MBA) degree from Brigham Young University and an MS degree in biotechnology from Johns Hopkins University. John Bergin is a pseudonym of the author.

Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Global Biochip Markets: Microarrays and Lab-on-a-Chip402Free
Chapter- 1: INTRODUCTION4Free
Chapter- 2: SUMMARY2Free
Chapter- 3: OVERVIEW10Free
Chapter- 4: MICROARRAY TECHNOLOGIES29Free
Chapter- 5: LAB-ON-A-CHIP TECHNOLOGIES13Free
Chapter- 6: DRUG DISCOVERY AND DEVELOPMENT APPLICATIONS13Free
Chapter- 7: DIAGNOSTICS APPLICATIONS81Free
Chapter- 8: BIOCHIPS INDUSTRY48Free
Chapter- 9: BIOCHIPS MARKETS47Free
Chapter- 10: BIOCHIPS PATENTS5Free
Chapter- 11: C. CRAMER & CO. GMBH150Free

Related Reports

Next Generation Sequencing: Emerging Clinical Applications and Global Markets

Published - Jul 2013 | Publisher - John Bergin | Code - BIO126A

The next generation sequencing market reached $231.7 million in 2012. The market is expected to reach $510.7 million in 2013 and $7.6 billion in 2018 for a compound annual growth rate (CAGR) of 71.6%.

DNA Sequencing: Emerging Technologies and Applications

Published - Mar 2012 | Publisher - John Bergin | Code - BIO045D

The global market for sequencing products was nearly $3 billion in 2011, and it is forecast to grow at a compound annual growth rate (CAGR) of 17.5% to reach $6.6 billion by 2016.

Global Biochip Markets: Microarrays and Lab-on-a-Chip

Published - Aug 2011 | Publisher - John Bergin | Code - BIO049D

The global value of the overall biochips market, by end use was $3.5 billion in the year 2010. The size of the biochips market will increase from $3.9 billion in 2011 to nearly $9.6 billion by 2016, a compound annual growth rate (CAGR) of 19.5%.

Next-Generation Cancer Diagnostics: Technologies and Global Markets

Published - Apr 2011 | Publisher - John Bergin | Code - BIO081A

The total global annual market for next generation cancer diagnostics was $776 million in 2010, and is growing at a compound annual growth rate (CAGR) of 47%, to reach a forecast market size of $5.3 billion in 2015.

Track the Latest Global Tariff Developments

In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.

Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.

Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.

With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.

Ready to see what tariff means for your business?

Consult with our experts or request your custom Tariff Impact Brife today

Stay Informed, Stay Competitive

In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.

Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.

Our analysis includes:

  • Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
  • Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
  • Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.

With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.

Don't let tariffs catch you off guard—let our insights guide your strategy.

This is an Excel-only version of the report.

Report Includes

    Total Number of Tables in this Report: 144

  • Summary Table: GLOBAL VALUE OF BIOCHIP PRODUCTS BY END USE, THROUGH 2018
  • Table 1: BIOLOGY DOWNSIZING REVOLUTION
  • Table 2: COMPARISON OF THE TWO MAJOR BIOCHIP TYPES
  • Table 3: BIOCHIP NOMENCLATURE
  • Table 4: SCOPE OF REPORT
  • Table 5: GLOBAL VALUE OF BIOCHIP PRODUCTS BY BIOCHIP TYPE, THROUGH 2018
  • Table 6: GLOBAL VALUE OF BIOCHIPS BY ANALYSIS FUNCTION, THROUGH 2018
  • Table 7: BIOCHIPS KEY MARKET GROWTH DRIVING FORCES
  • Table 8: COMPARISON OF BIOCHIPS INDUSTRIES
  • Table 9: THE NANOSCALE WORLD
  • Table 10: MICROARRAY TYPES
Sample Report

Recent Reports

Separation Systems for Commercial Biotechnology

Published - Oct 2025 | Publisher - BCC Publishing | Code - BIO011H

The global market for bioseparation systems is expected to grow from $32.5 billion in 2025 and is projected to reach $45.1 billion by the end of 2030, at a compound annual growth rate (CAGR) of 6.8% during the forecast period of 2025 to 2030.

Biomarker Deals: Terms Value and Trends 2019-2025

Published - Sep 2025 | Publisher - BCC Publishing | Code - BIO169B

This report provides an analysis of strategic transactions encompassing licensing, acquisitions and collaborations in the global biomarker market. It focuses on deals executed between 2019 and 2025, providing a retrospective assessment of deal-making activity to identify emerging trends, investment behaviors and strategic priorities in the biomarker landscape.

mRNA: Therapeutics and Global Markets

Published - Sep 2025 | Publisher - BCC Publishing | Code - BIO212C

The global market for mRNA therapeutics was valued at $7.71 billion in 2025 and is forecast to remain stable or slightly decline to $7.69 billion by the end of 2030, at a compound annual growth rate (CAGR) of -0.04% during the forecast period of 2025 to 2030.

The Chinese Market for DNA Sequencing

Published - Sep 2025 | Publisher - BCC Publishing | Code - BIO152C

The Chinese DNA sequencing market is expected to grow from $1.2 billion in 2025 and is projected to reach $3.1 billion by the end of 2030, at a compound annual growth rate (CAGR) of 21.5% during the forecast period of 2025 to 2030.

Molecular Diagnostics: Technologies and Global Markets

Published - Sep 2025 | Publisher - BCC Publishing | Code - BIO063F

The global market for molecular diagnostics is expected to grow from $23 billion in 2025 and is projected to reach $42.6 billion by the end of 2030, at a compound annual growth rate (CAGR) of 13.1% during the forecast period of 2025 to 2030.

Published - Aug-2011| Analyst - John Bergin| Code - BIO049D

Report Highlights

The global value of the overall biochips market, by end use was $3.5 billion in the year 2010. The size of the biochips market will increase from $3.9 billion in 2011 to nearly $9.6 billion by 2016, a compound annual growth rate (CAGR) of 19.5%.

Published - Jan-2010| Analyst - John Bergin| Code - BIO049C

Report Highlights

  • The total market for biochips was $2.4 billion in 2008 which increased to $2.6 billion in 2009. This is expected to grow at compound annual growth rate (CAGR) of 17.7% to reach $5.9 billion by 2014
  • The DNA microarrays market was nearly $1.2 billion in 2008; this further increased to $1.3 billion in 2009, this projected to reach $2.7 billion in 2014, for a 5-year CAGR of 15.2%.
  • Sales in the LOAC market amounted to $755 million in 2008 which increased to $817 million in 2009. This is projected to increase to $2.1 billion in 2014, for a 5-year CAGR of 20.9%.
Published - Sep-2007| Analyst - John Bergin| Code - BIO049B

Report Highlights

  • The global market for biochips increased from $1,637.5 million in 2006 to an estimated $2,115.6 million by the end of 2008. It should reach $3,840.7 million in 2013, a compound annual growth rate (CAGR) of 12.7%.
  • DNA microarrays dominate the market today, expected to be worth $947.3 million in 2007, followed by lab-on-a-chip (LOAC), expected to be worth $625.8 million in 2007.
  • The largest market segment for biochips is in drug discovery and development.
Published - Jan-2004| Analyst - Sam Brauer| Code - BIO049A

Report Highlights

  • The total market for DNA microarrays and materials totaled $544.4 million in 2002. Rising at an AAGR (average annual growth rate) of 13.4%, this market is expected to just exceed $1 billion in 2007.
  • Microarrays themselves make up the bulk of the market and sales are expected to rise at an AAGR of 11.7% through 2007 to reach $744 million.
  • Materials sales will rise faster due to increasing complexity, reaching $275 million in 2007 at an AAGR of 18.8%.
  • Although DNA microarrays are entering a period of more modest growth (growth was at 30%/year just a few years ago), there are some dramatic changes taking place in the types of microarrays being produced.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Global Biochip Markets: Microarrays and Lab-on-a-Chip
Customize Report
AI: Your Say